0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R2,500 - R5,000 (2)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Hardcover, 1st ed. 2017): Ulf Grawunder, Stefan Barth Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Hardcover, 1st ed. 2017)
Ulf Grawunder, Stefan Barth
R4,649 Discovery Miles 46 490 Ships in 12 - 17 working days

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Paperback, Softcover reprint of the original 1st ed. 2017):... Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Paperback, Softcover reprint of the original 1st ed. 2017)
Ulf Grawunder, Stefan Barth
R4,228 Discovery Miles 42 280 Ships in 10 - 15 working days

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Mountain Backgammon - The Classic Game…
Lily Dyu R575 R460 Discovery Miles 4 600
Cracker Island
Gorillaz CD R207 R148 Discovery Miles 1 480
First Dutch Brands Isla Plant Stand…
R115 Discovery Miles 1 150
Elvis
Baz Luhrmann Blu-ray disc R191 R171 Discovery Miles 1 710
Parker Jotter Original Ballpoint Pen…
R199 R157 Discovery Miles 1 570
Benetton Benetton Sport Eau De Toilette…
R1,057 Discovery Miles 10 570
Knock At The Cabin
Dave Bautista, Jonathan Groff, … DVD R133 Discovery Miles 1 330
Kiddylicious Cheese Straws (12g)
 (2)
R28 R24 Discovery Miles 240
Home Classix Placemats - Blooming…
R59 R51 Discovery Miles 510
Slippers
R57 Discovery Miles 570

 

Partners